These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24703488)

  • 1. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.
    Mehta G; Mookerjee RP; Sharma V; Jalan R
    Liver Int; 2015 Mar; 35(3):724-34. PubMed ID: 24703488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
    Clària J; Moreau R; Fenaille F; Amorós A; Junot C; Gronbaek H; Coenraad MJ; Pruvost A; Ghettas A; Chu-Van E; López-Vicario C; Oettl K; Caraceni P; Alessandria C; Trebicka J; Pavesi M; Deulofeu C; Albillos A; Gustot T; Welzel TM; Fernández J; Stauber RE; Saliba F; Butin N; Colsch B; Moreno C; Durand F; Nevens F; Bañares R; Benten D; Ginès P; Gerbes A; Jalan R; Angeli P; Bernardi M; Arroyo V;
    Hepatology; 2019 Apr; 69(4):1686-1701. PubMed ID: 30521097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study.
    Pompili E; Baldassarre M; Bedogni G; Zaccherini G; Iannone G; De Venuto C; Pratelli D; Palmese F; Domenicali M; Caraceni P
    Liver Int; 2024 Jan; 44(1):72-82. PubMed ID: 37718730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.
    Garg H; Kumar A; Garg V; Kumar M; Kumar R; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1361-7. PubMed ID: 23488990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.
    Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J
    Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death markers in patients with cirrhosis and acute decompensation.
    Macdonald S; Andreola F; Bachtiger P; Amoros A; Pavesi M; Mookerjee R; Zheng YB; Gronbaek H; Gerbes AL; Sola E; Caraceni P; Moreau R; Gines P; Arroyo V; Jalan R
    Hepatology; 2018 Mar; 67(3):989-1002. PubMed ID: 29023872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
    Lehmann JM; Claus K; Jansen C; Pohlmann A; Schierwagen R; Meyer C; Thomas D; Manekeller S; Claria J; Strassburg CP; Trautwein C; Wasmuth HE; Berres ML; Trebicka J
    Liver Int; 2018 May; 38(5):875-884. PubMed ID: 29105936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
    Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
    J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
    Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
    Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients.
    Shalimar ; Rout G; Jadaun SS; Ranjan G; Kedia S; Gunjan D; Nayak B; Acharya SK; Kumar A; Kapil A
    Dig Liver Dis; 2018 Nov; 50(11):1225-1231. PubMed ID: 29910108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
    Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
    J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
    Prasanna KS; Goel A; Amirtharaj GJ; Ramachandran A; Balasubramanian KA; Mackie I; Zachariah U; Sajith KG; Elias E; Eapen CE
    Indian J Gastroenterol; 2016 Nov; 35(6):432-440. PubMed ID: 27822882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
    Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
    Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
    Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.